Citations

Showing 10 of 108104 citations.

The Benefit of Supplemental Nutrition Education for Severely Malnourished Patients Awaiting Liver Transplant
Chaney, Amanda , Chaney, Amanda J, Heckman, Michael G.

Mayo Clinic

Progress in Transplantation | September 24, 2018 | Volume: 28 | Issue: 4 | Pages: 390-393

10.1177/1526924818800052 | PMID 30244656 Get It

Introduction: Nutritional interventions improve patient outcomes and reduce mortality in patients with cirrhosis by reducing infection risk, ascites, length of stay in hospital and intensive care unit, and mortality. Follow-up phone calls have been found to be useful in improving patient adherence to therapy. Problem: The purpose of this quality improvement project was to determine whether supplemental nutrition education would improve nutrition and outcomes among patients with cirrhosis who are undergoing a liver transplant evaluation. In addition, we sought to measure patient adherence with nutritional recommendations and whether patients perceived this additional education improved their nutrition status. Methods: The Plan-Do-Study-Ask methodology was used. Processes: Addressed 8 patients were enrolled to participate in the supplemental nutrition education, after which they received 3 follow-up phone calls. A retrospective review of data from 10 patients meeting project inclusion criteria were identified by the nutrition specialist and were used as a comparison group. Data were analyzed using descriptive statistics; comparing data from before and after implementation of the supplemental nutrition education was done. Outcomes: At the end of the 8-week project period, 4 (66.7%) patients reported weight loss since the time of enrollment (nutrition education class), and the median patient-generated subjective global assessment score increased by 4 points, rather than decreasing as expected. However, all patients reported they believed the phone calls improved their nutrition status. Implications: With a multidisciplinary approach, this additional patient education may improve patient care and outcomes.
Incidence and Treatment Trends of Symptomatic Discoid Lateral Menisci: An 18-Year Population-Based Study
Sabbag, Orlando D., Sanders, Thomas L. , Dahm, Diane L., Levy, Bruce A. , Krych, Aaron J. , Krych, Aaron J , Hevesi, Mario , Camp, Christopher L. , Stuart, Michael J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | September 24, 2018 | Volume: 6 | Issue: 9 | Pages: No page available

10.1177/2325967118797886 | PMID 30263899 Get It

Background: A symptomatic discoid lateral meniscus is an uncommon orthopaedic abnormality, and the majority of information in the literature is limited to small case series. Purpose/Hypothesis: The purpose of this study was to determine the incidence of symptomatic discoid menisci in a geographically determined population and to describe treatment trends over time. The hypothesis was that the incidence of symptomatic discoid menisci would be highest among adolescent patients, and thus, the rate of surgical treatment would be high compared with nonoperative treatment. Study Design: Descriptive epidemiology study. Methods: The study population included 79 patients in Olmsted County, Minnesota, identified through a geographic database, who were diagnosed with a symptomatic discoid lateral meniscus between 1998 and 2015. The complete medical records were reviewed to confirm the diagnosis and evaluate the details of injury and treatment. Age- and sex-specific incidence rates were calculated and adjusted to the 2010 United States population. Results: The overall annual incidence of symptomatic discoid lateral menisci was 3.2 (95% CI, 2.5-3.9) per 100,000 person-years; 12.6% of the patients in the cohort had bilateral symptomatic discoid lateral menisci. The overall annual incidence was similar between male (3.5 per 100,000 person-years) and female patients (2.8 per 100,000 person-years). The highest incidence of symptomatic discoid lateral menisci was noted in adolescent male patients aged 15-18 years (18.8 per 100,000 person-years). A majority (72.2%) of patients presented with a symptomatic tear of the discoid meniscus. The remaining patients presented with mechanical symptoms, including catching/locking or effusion, with no demonstrable meniscus tear on imaging or diagnostic arthroscopic surgery. Additionally, 20.0% of patients were observed to have peripheral instability of the meniscus at the time of diagnostic arthroscopic surgery. The mean age of those with peripheral instability was significantly younger than of those who did not have peripheral instability. Sixty patients (75.9%) received surgical treatment during the study period, including 49 (81.7%) patients who underwent partial lateral meniscectomy and 11 (18.3%) patients who underwent lateral meniscus repair in addition to saucerization. Conclusion: With an overall annual incidence of 3.2 per 100,000 person-years, a symptomatic discoid meniscus is an uncommonly encountered orthopaedic abnormality. However, the incidence of symptomatic discoid lateral menisci is highest in adolescent male patients. Because of the high rate of meniscus tears in patients presenting with symptoms, the majority are treated surgically.
TIEG1 is upregulated in Lrp5/6‐mediated valve osteogenesis
Rajamannan, Nalini M.

Mayo Clinic

Journal of Cellular Biochemistry | September 24, 2018 | Volume: 120 | Issue: 3 | Pages: 3362-3366

10.1002/jcb.27606 | PMID 30246479 Get It

AbstractWe have previously demonstrated that Lrp5/6/β‐catenin plays an important role in valve calcification with a specific osteogenic phenotype defined by increased bone mineral content and overall valve thickening. Recent studies indicate that TIEG1 may be involved in mediating the Wnt signaling pathway in bone, which is known to play critical roles in osteoblast differentiation and bone mineralization. Therefore, we sought to test the role of TIEG1 in mediating Wnt signaling, in an established model of hypercholesterolemic valve disease. Our previous model treated null mice with cholesterol diets: Lrp5 −/−/ApoE −/− mice versus wild‐type control (n = 180). Group I (n = 60) normal diet, Group II (n = 60) 0.25% chol diet (w/w), and Group III (n = 60) 0.25% (w/w) chol diet + atorv was tested for gene expression for TIEG1, Lrp6, and Runx2. Real‐time polymerase chain reaction confirmed that there is upregulation of the gene expression for TIEG1 and Runx2 in the hypercholesterolemic double knockout and single knockout valves as compared with controls with a mild increase in Lrp6. To confirm the mechanism, coexpression of β‐catenin, TIEG1, and LEF1 in valve cells in vitro, led to the coactivation of the TOPFLASH reporter, which was further confirmed by the observation that TIEG1 and β‐catenin colocalize with one another in the nucleus of valvular interstitial cells (VICs) following stimulation with transforming growth factor‐β treatment, an established activator of TIEG1. Taken together, these data implicate an important role for TIEG1 in mediating valve osteogenesis.
Evaluation of medication list accuracy from hospital discharge to first outpatient follow‐up
Irvin, Myra, Bates, Allan A., Hiroto, Brett T., Heckman, Alexander , Mareth, Karl , Williams, Shamol, Parkulo, Mark A. , Sacco, Keith

Mayo Clinic

Journal of Pharmacy Practice and Research | September 24, 2018 | Volume: 48 | Issue: 5 | Pages: 437-441

10.1002/jppr.1446 Get It

AbstractBackgroundMedication discrepancies are common between transitions in healthcare and are associated with higher healthcare utilisation and hospital readmission following discharge. Medication reconciliation is a key intervention to reduce medication list discrepancy. The transition between discharge and first outpatient appointment is critical for patient recovery. The proportion of medication discrepancies during this interval is not well characterised.AimThe aim of this study was to evaluate the accuracy of patients’ medication list between discharge from hospital or emergency department to first outpatient follow‐up with their primary care physician.MethodsA cross‐sectional observational study was performed between November 2015 and May 2016. A 10‐question survey was designed to identify potential areas of inaccuracies in the medication lists.ResultsIn all, 106 patients completed the survey, of whom 67.9% (n = 72) had complete data. Eighty per cent of patients (n = 85) had a provider review their medication list prior to discharge. At the time of follow‐up, 22.6% (n = 28) were not taking the listed medications; of this cohort, 35% (n = 8) had a physician instruct them to stop taking medication. Six per cent of patients (n = 6) reported incorrect medication doses.ConclusionMedication discrepancies occur in the transition from hospital discharge to first follow‐up. This poses a threat to patient safety. A standardised process of medication review is critical to prevent such errors.
Postoperative Pulmonary Edema Conundrum: A Case of Negative Pressure Pulmonary Edema
Guru, Pramod , Agarwal, Anjali , Pimentel, Mario, Guru, Pramod K , McLaughlin, Diane C, McLaughlin, Diane , Bansal, Vikas

Mayo Clinic

Case Reports in Critical Care | September 23, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-3

10.1155/2018/1584134 | PMID 30345119 Get It

Postobstructive pulmonary edema (POPE) also known as negative pressure pulmonary edema (NPPE) is an underdiagnosed entity in clinical practice and can lead to life-threatening hypoxemia. A 64-year-old male patient’s perioperative course was complicated by acute hypoxemic respiratory failure, after extubation following general anesthesia, following the excision of the right vocal cord papilloma. His chest X-ray showed features of pulmonary edema, EKG showed dynamic ST-T changes in the lateral leads, and echocardiography showed evidence of regional motion abnormalities. His coronaries were normal on the immediate angiogram. He was managed with lung protective mechanical ventilation strategy, diuretics, and fluid restriction. His respiratory status improved, and trachea was extubated after 10 hours of intensive care unit (ICU) stay. The case illustrates the various differentials of immediate postoperative flash pulmonary edema and ensuing appropriate management strategy.
Reproducibility of Liver‐to‐Thorax Area Ratio Ultrasound Measurements in Congenital Diaphragmatic Hernia
Novoa, Victoria Arruga Novoa y, Sutton, Laura F., Neis, Allan E., Marroquin, Amber M., Coleman, Tracey M., Praska, Kathleen A., Freimund, Tamara A., Ruka, Krystal L., Warzala, Vicki L., Sangi‐Haghpeykar, Haleh , Novoa Y Novoa, Victoria Arruga, Ruano, Rodrigo

Mayo Clinic

Journal of Ultrasound in Medicine | September 23, 2018 | Volume: 38 | Issue: 6 | Pages: 1477-1482

10.1002/jum.14826 | PMID 30244491 Get It

ObjectivesThe aim of this study was to investigate the reproducibility of a standardized method to assess the ultrasound liver‐to‐thoracic area ratio in fetuses with congenital diaphragmatic hernia.MethodsWe selected 24 images of 9 fetuses diagnosed with left‐sided at our institution between January 2010 and December 2017. Eight operators (1 maternal‐fetal medicine specialist and 7 sonographers) reviewed the selected images and assessed the ultrasound liver‐to‐thoracic area ratio according to a standardized protocol. We evaluated the correlation between operators using the intraclass correlation coefficient and compared agreement between the sonographers and a physician with experience in measuring the ultrasound liver‐to‐thoracic area ratio using a Bland‐Altman analysis.ResultsGood intraoperator reproducibility was observed for the standardized ultrasound liver‐to‐thoracic area ratio (intraclass correlation coefficient, 0.78). Good agreement among sonographers and the physician was also observed for the standardized measurements (bias, 0.01; precision, 0.03; limits of agreement, –0.05 to + 0.07).ConclusionsWe demonstrated that good intraoperator and interoperator reproducibility of ultrasound liver‐to‐thoracic area ratio assessment is feasible after standardizing the method in our center.
A hybrid technique for treatment of commissural primary mitral regurgitation
Raphael, Claire E. , Malouf, Joseph F., Maor, Elad , Panaich, Sidakpal , Pollak, Peter , Reeder, Guy S., Rihal, Charanjit S. , Eleid, Mackram F. , Panaich, Sidakpal S , Pollak, Peter M, Raphael, Claire , Maor, Elad , Rihal, Charanjit S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | September 23, 2018 | Volume: 93 | Issue: 4 | Pages: 692-698

10.1002/ccd.27904 | PMID 30244543 Get It

AbstractBackgroundMitraClip is an effective transcatheter therapy for mitral regurgitation (MR). However, MitraClip is challenging in commissural MR and the optimal therapeutic approach is unclear.MethodsWe describe a case series of six consecutive patients with severe commissural primary mitral regurgitation who underwent MitraClip insertion followed by an Amplatzer Vascular Plug (AVP) II occluder between the commissure and the MitraClip.ResultsThe procedure was successful in all patients. MR was reduced from severe to mild/trivial in 50% and moderate in 50% of cases. On 30‐day follow‐up, NYHA class had improved from III (6 patients) to I (2 patients), II (2 patients), and III (2 patients). The mean transmitral gradient was 2.5 ± 1.8 mmHg at baseline and 4.8 ± 2.6 mmHg following the procedure. One patient developed hemolysis immediately post procedure. The other five patients remained well during a median follow‐up of 20 months (range 5–50 months) with no reported device dislodgement.ConclusionsElective treatment of severe commissural MR with a laterally or medially placed MitraClip coupled with an AVP II occluder between the clip and the commissure is feasible and safe. This approach may provide a useful management alternative in selected patients.
Anti-Tumour Necrosis Factor Therapy for Inflammatory Bowel Diseases Do Not Impact Serious Infections after Arthroplasty
Gregory, Martin , Stwalley, Dustin , Hippensteel, K. J. , Loftus, Edward V. , Ciorba, Matthew A. , Deepak, Parakkal , Loftus, Edward V , Deepak, Parakkal , McKinnon, Andrew, Olsen, Margaret A A

Mayo Clinic

Journal of Crohn's and Colitis | September 22, 2018 | Volume: 13 | Issue: 2 | Pages: 182-188

10.1093/ecco-jcc/jjy148 | PMID 30256926 Get It

Intramuscular interstitial amyloid deposition does not impact anoctaminopathy‐5 phenotype
Anandan, Charenya, Milone, Margherita , Liewluck, Teerin , Liewluck, T

Mayo Clinic

Muscle & Nerve | September 22, 2018 | Volume: 59 | Issue: 1 | Pages: 133-137

10.1002/mus.26349 | PMID 30320887 Get It

ABSTRACT Introduction: Recessive mutations in the anoctamin‐5‐encoding gene (ANO5) cause muscular dystrophy of various phenotypes. Intramuscular interstitial amyloid deposits were detected in a few patients with anoctaminopathy‐5, some with cardiac involvement. The frequency of amyloid deposition in anoctaminopathy‐5 and its impact on phenotype are unknown. Methods: We retrospectively identified patients with genetically proven anoctaminopathy‐5 who had undergone muscle biopsy and reviewed their clinical and laboratory data. Results: Eight of 15 patients with anoctaminopathy‐5 had intramuscular interstitial amyloid deposits. The median age at onset of weakness was 40 and 45 years in the amyloidosis and nonamyloidosis groups, respectively. Mutations occurred throughout the entire gene in the amyloidosis group. Atrial arrhythmia was noted in 4 patients with amyloidosis and in 4 patients without amyloidosis. The latter group also had premature ventricular contractions. One nonamyloidosis patient had septal hypokinesia. Discussion: Intramuscular amyloidosis occurred in 53% of patients with anoctaminopathy‐5 who underwent muscle biopsy and had no impact on the phenotype. Muscle Nerve 59:133–137, 2019
Chimeric Antigen Receptor T‐Cells: Successful Translation of the First Cell and Gene Therapy From Bench to Bedside
Rodriguez‐Cartagena, Luis G., Kurani, Shaheen , Windebank, Anthony J. , Greenberg, Alexandra J. , Bowles, Bradley S, Kurani, Shaheen S, Kenderian, Saad S. , Greenberg-Worisek, Alexandra J, Rodriguez-Cartagena, Luis G, Bowles, Bradley

Mayo Clinic

Clinical and Translational Science | September 22, 2018 | Volume: 11 | Issue: 6 | Pages: 537-539

10.1111/cts.12586 | PMID 30242965 Get It